MNC: Difference between revisions
Created page with "a multinational pharmaceutical or pharma-biotechnology company with commercial presence in North America, Europe and the People's Republic of China and a market capitalization of at least a hundred billion Dollars" |
No edit summary |
||
| Line 1: | Line 1: | ||
‘a multinational pharmaceutical or pharma-biotechnology company with commercial presence in North America, Europe and the People's Republic of China and a market capitalization of at least a hundred billion Dollars’ (https://ir.nanobiotix.com/static-files/8f672c73-fe44-441b-a1d5-a87e06db4be5) | |||
[[Category:Terms]] | |||
[[Category:Medical]] | |||
{{Back to the top}} | |||
Latest revision as of 09:55, 23 July 2024
‘a multinational pharmaceutical or pharma-biotechnology company with commercial presence in North America, Europe and the People's Republic of China and a market capitalization of at least a hundred billion Dollars’ (https://ir.nanobiotix.com/static-files/8f672c73-fe44-441b-a1d5-a87e06db4be5)